Transaction · 0000950170-25-008963

WILSON JAMES N

WILSON JAMES N, DIR, reported a transaction classified as other at CORCEPT THERAPEUTICS INC involving 146742.000000 shares for an estimated $0.00. Reported holdings after the transaction were 1452968.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

otherSEC transaction code JDIR
CORTCORCEPT THERAPEUTICS INC
Filing timeJan 25
Trade dateJan 22, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

CORT price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
CORT since 2025-01-25Filed 587 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
other
Code J
Identifier
0000950170-25-008963
Common Stock
Transaction date
Jan 22, 2025
Filed Jan 25, 2025, 01:20 AM · 3d delay
Shares
146k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
1.45M sh
Indirect · James N. Wilson and Pamela D. Wilson Trust

Filing warnings

Notes recorded with this filing
1 warning
ambiguous transaction codeThe transaction code is missing or represents other activity; review the filing and footnotes.
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability arising from a net (cashless) exercise of stock options that occurred on January 22, 2025.

  2. F2

    Transfer of shares without consideration to the James N. Wilson and Pamela D. Wilson Trust.

  3. F3

    Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims benefic…

  4. F4

    Fully exercisable.

Original filing · 0000950170-25-008963
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

CORT